Annual Cash & Cash Equivalents
$49.90 M
+$33.24 M+199.56%
December 31, 2023
Summary
- As of February 7, 2025, APLT annual cash & cash equivalents is $49.90 million, with the most recent change of +$33.24 million (+199.56%) on December 31, 2023.
- During the last 3 years, APLT annual cash & cash equivalents has fallen by -$7.57 million (-13.17%).
- APLT annual cash & cash equivalents is now -13.17% below its all-time high of $57.47 million, reached on December 31, 2020.
Performance
APLT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$98.87 M
-$23.33 M-19.09%
September 30, 2024
Summary
- As of February 7, 2025, APLT quarterly cash and cash equivalents is $98.87 million, with the most recent change of -$23.33 million (-19.09%) on September 30, 2024.
- Over the past year, APLT quarterly cash and cash equivalents has increased by +$61.41 million (+163.95%).
- APLT quarterly cash and cash equivalents is now -32.51% below its all-time high of $146.48 million, reached on March 31, 2024.
Performance
APLT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
APLT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +199.6% | +163.9% |
| 3 y3 years | -13.2% | +40.8% |
| 5 y5 years | +166.2% | +424.5% |
APLT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.4% | +199.6% | -32.5% | +493.6% |
| 5 y | 5-year | -13.2% | +199.6% | -32.5% | +493.6% |
| alltime | all time | -13.2% | +1422.7% | -32.5% | +656.7% |
Applied Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $98.87 M(-19.1%) |
| Jun 2024 | - | $122.20 M(-16.6%) |
| Mar 2024 | - | $146.48 M(+193.6%) |
| Dec 2023 | $49.90 M(+199.6%) | $49.90 M(+33.2%) |
| Sep 2023 | - | $37.46 M(+5.2%) |
| Jun 2023 | - | $35.62 M(+55.4%) |
| Mar 2023 | - | $22.92 M(+37.6%) |
| Dec 2022 | $16.66 M(-69.1%) | $16.66 M(-58.8%) |
| Sep 2022 | - | $40.39 M(-27.5%) |
| Jun 2022 | - | $55.73 M(+45.8%) |
| Mar 2022 | - | $38.21 M(-29.1%) |
| Dec 2021 | $53.89 M | $53.89 M(-23.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $70.21 M(-10.5%) |
| Jun 2021 | - | $78.43 M(-6.7%) |
| Mar 2021 | - | $84.07 M(+46.3%) |
| Dec 2020 | $57.47 M(+204.9%) | $57.47 M(+18.1%) |
| Sep 2020 | - | $48.68 M(-51.7%) |
| Jun 2020 | - | $100.85 M(+9.0%) |
| Mar 2020 | - | $92.50 M(+390.7%) |
| Dec 2019 | $18.85 M(+0.5%) | $18.85 M(+44.3%) |
| Sep 2019 | - | $13.06 M(-68.2%) |
| Jun 2019 | - | $41.08 M(+179.7%) |
| Mar 2019 | - | $14.69 M(-21.7%) |
| Dec 2018 | $18.75 M(+472.1%) | $18.75 M |
| Dec 2017 | $3.28 M | - |
FAQ
- What is Applied Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Applied Therapeutics?
- What is Applied Therapeutics annual cash & cash equivalents year-on-year change?
- What is Applied Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Applied Therapeutics?
- What is Applied Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Applied Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of APLT is $49.90 M
What is the all time high annual cash & cash equivalents for Applied Therapeutics?
Applied Therapeutics all-time high annual cash & cash equivalents is $57.47 M
What is Applied Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, APLT annual cash & cash equivalents has changed by +$33.24 M (+199.56%)
What is Applied Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of APLT is $98.87 M
What is the all time high quarterly cash and cash equivalents for Applied Therapeutics?
Applied Therapeutics all-time high quarterly cash and cash equivalents is $146.48 M
What is Applied Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, APLT quarterly cash and cash equivalents has changed by +$61.41 M (+163.95%)